QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:06 UTC · Public disclosure record

97AVG SCORE

Robert Aderholt

House Republican AL
House Committee on Appropriations
Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesDefenseLabor, Health and Human Services, Education, and Related Agencies

Robert Aderholt has disclosed 3 stock transactions — 1 buy, 2 sells, each ranked by how much scrutiny it deserves and linked to its original House filing. A transparency record.

3
Total trades
1
Buy
2
Sell
5
Avg. disclosure delay (days)
Estimated net worth 2024 financial disclosure · source ↗
$3,465,060 – $10,802,000
A range, because disclosures report assets and liabilities only in bands — never an exact figure. It's what lets us gauge how big each trade is relative to Aderholt's own wealth (the % of NW tags in the table below), so a small portfolio taking a real swing stands apart from pocket change. An estimate for context, not an allegation.

Track record Congressional Trading Performance

Two figures per horizon, both hypothetical and not investment advice: Member's own — what the trade returned if you'd bought when Aderholt did (not public yet, so not replicable); and If you'd followed — buying only after the disclosure went public, which is what a follower could actually do. The gap between them is the cost of the disclosure lag.

1 month
no price data
0 of 1 priced
3 months
no price data
0 of 1 priced
6 months
no price data
0 of 1 priced
1 year
no price data
0 of 1 priced
3 years
no price data
0 of 1 priced

We don't have price history covering Aderholt's trades — they may predate our price data or be on tickers we don't track — so hypothetical returns can't be computed here. The disclosures themselves are all listed below.

Where they trade Favorite Sectors

Distribution of this politician's trades across sectors (of trades with a known sector — bonds and funds are excluded).

Health
1 (33%)
Transportation
1 (33%)
Technology
1 (33%)

Traded the same stocks, same time Co-Investors in Congress

Other members who traded the same tickers within 30 days of Aderholt's trades in them. A high overlap can reflect shared information, shared advisors, or simply popular stocks — it is not evidence of coordination.

PoliticianOverlapping tradesShared tickers
Kathy Manning 4 AAPL
Josh Gottheimer 2 AAPL, TSLA
Bob Gibbs 2 AAPL
Lisa McClain 1 GSK
Nancy Pelosi 1 TSLA
Michael Garcia 1 TSLA
Christopher Jacobs 1 TSLA

3 trades Recent Transactions

Marker key: ⚑ potential conflict (a committee Aderholt sits on oversees that sector) · ◆ corporate-insider overlap from SEC Form 4 (convergence/divergence — context, not a signal) · % of NW trade size vs estimated net worth, 🔥 marking high/extreme conviction · OCR recovered from a scanned filing (verify against source) · ×N filings the same trade disclosed more than once (shown once). None is an allegation of wrongdoing.

TickerCompanyTypeDateFiledLagPrice move
in that
window
AmountScoreSource
GSK Gsk plc SELL 2025-07-28 2025-08-11 14 days +0.7% $1K–$15K
0.1% of NW
93.5 ↗ filing
TSLA Tesla, Inc. SELL ◆ insider convergence 2022-12-05 2022-12-05 0 days — $1K–$15K
0.1% of NW
99.5 ↗ filing
AAPL Apple Inc. BUY 2022-08-26 2022-08-26 0 days — $1K–$15K
0.1% of NW
98.6 ↗ filing

FAQ Common questions

How many stock trades has Robert Aderholt disclosed?

3 disclosed stock transactions — 1 buys and 2 sells — all from official House financial disclosures.

Is this insider trading?

No. QuantCapitol surfaces the timing and context of publicly disclosed trades for transparency. A trade near related legislation is a coincidence we flag — never an accusation of wrongdoing.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.